drugset / Trial / NCT02238444
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether Warfarin Anticoagulation are effective and safe in Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients with Hypersplenism after Laparoscopic Splenectomy.
Timeline
- Start
- 2014-09-01
- Primary completion
- 2019-09-30
- Completion
- 2019-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | Oral |
| Subject | Warfarin | Small molecule | 2.5 mg | Oral |
| Background | Dipyridamole | Other / unclassified | 25 mg | Oral |
| Background | Nadroparin Calcium | Other / unclassified | 4100 iu | Subcutaneous |